Nemechek Technologies, LLC

Utilizing a smartphone-enabled neuromodulator to reduce inflammation and restore health as part of a patented treatment regimen called The Nemechek Protocol®. A growing scientific consensus now believes that inflammation is often the triggering and driving force behind such common illnesses as diabetes, cancer, heart attacks, strokes, hypertension, chronic depression and autoimmune disorders such as rheumatoid arthritis, Crohn's disease and ulcerative colitis. Chronic inflammatory diseases are predicted to be the cause of death in the 3 out of every 5 persons worldwide (World Health Organization, 2017). Estimates suggest that 60% of U.S. population has at least 1 condition caused by chronic inflammation. In addition, 60% of Americans are taking daily, long term and often expensive medications to control these inflammatory diseases. Daily medications that could be reduced or replaced with the use of neuromodulation of the vagus nerve. Using electrical stimulation of the vagus nerve to address these chronic diseases is the next disruptive therapy in medicine. Many factors are coming together to make this the decade when we can take bioelectronic therapy from a promising biological concept to neuromodulation devices that can provide meaningful health benefits to patients.

• Employees 2
• Founded 2019